Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection

References

• Rogers DF. Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care. 2007;52(9):1134–1146.17716382
   PubMed Web of Science ®Google Scholar
• Finkbeiner WE. Physiology and pathology of tracheobronchial glands. Respir Physiol. 1999;118(2–3):77–83. doi:10.1016/S0034-5687(99)00080-810647853
   PubMedGoogle Scholar
• Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86(1):245–278. doi:10.1152/physrev.00008.200616371599
   PubMed Web of Science ®Google Scholar
• Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233–2247. doi:10.1056/NEJMoa101120521121836
   PubMed Web of Science ®Google Scholar
• Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J. 1999;13(5):1177–1188. doi:10.1034/j.1399-3003.1999.13e39.x10414423
   PubMed Web of Science ®Google Scholar
• Maestrelli P, Saetta M, Mapp CE, Fabbri LM. Remodeling in response to infection and injury: airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(10 Pt 2):S76–80. doi:10.1164/ajrccm.164.supplement_2.210606711734472
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang YY, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Adv Drug Deliv Rev. 2009;61(2):86–100. doi:10.1016/j.addr.2008.09.01219166889
   PubMed Web of Science ®Google Scholar
• Balsamo R, Lanata L, Egan CG. Mucoactive drugs. Eur Respir Rev. 2010;19(116):127–133. doi:10.1183/09059180.0000351020956181
   PubMedGoogle Scholar
• Parvez L, Vaidya M, Sakhardande A, Subburaj S, Rajagopalan TG. Evaluation of antitussive agents in man. Pulm Pharmacol. 1996;9(5–6):299–308. doi:10.1006/pulp.1996.00399232667
   PubMedGoogle Scholar
• Yuta A, Baraniuk JN. Therapeutic approaches to mucus hypersecretion. Curr Allergy Asthma Rep. 2005;5(3):243–251. doi:10.1007/s11882-005-0044-615842963
   PubMed Web of Science ®Google Scholar
• Seagrave J, Albrecht HH, Hill DB, Rogers DF, Solomon G. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells. Respir Res. 2012;13:98. doi:10.1186/1465-9921-13-9823113953
   PubMed Web of Science ®Google Scholar
• FDA. Cold, cough, allergy, bronchodilator and antiasthmatic drug products for over-the-counter human use; Final monograph. Fed Regist. 1989;54:8494–8509.
   Google Scholar
• Robinson RE, Cummings WB, Deffenbaugh ER. Effectiveness of guaifenesin as an expectorant: a cooperative double-blind study. Curr Ther Res. 1977;22(2):284–296.
   Web of Science ®Google Scholar
• Kuhn JJ, Hendley JO, Adams KF, Clark JW, Gwaltney JM Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest. 1982;82(6):713–718. doi:10.1378/chest.82.6.7136754274
   PubMed Web of Science ®Google Scholar
• Dicpinigaitis PV, Gayle YE. Effect of guaifenesin on cough reflex sensitivity. Chest. 2003;124(6):2178–2181. doi:10.1378/chest.124.6.217814665498
   PubMed Web of Science ®Google Scholar
• Mucinex® (guaifenesin) [package insert]. Parsippany, NJ: Reckitt Benckiser LLC; 2016.
   Google Scholar
• Albrecht H, Vernon M, Solomon G. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms. Respir Res. 2012;13:118. doi:10.1186/1465-9921-13-11823270519
   PubMed Web of Science ®Google Scholar
• Hoffer-Schaefer A, Rozycki HJ, Yopp MA, Rubin BK. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections. Respir Care. 2014;59(5):631–636. doi:10.4187/respcare.0264024003241
   PubMed Web of Science ®Google Scholar
• Bennett WD, Kala A, Duckworth H, et al. Effect of a single 1200 mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection. Respir Med. 2015;109(11):1476–1483. doi:10.1016/j.rmed.2015.09.01726462765
   PubMed Web of Science ®Google Scholar
• Bennet W, Kala A, Zeman K, et al. Effect of oral guaifenesin (Mucinex® 1200 mg) on mucociliary clearance from the lungs of healthy, non-smoking adults. Poster presented at: European Respiratory Society Annual Congress; 9 18–22, 2010; Barcelona, Spain.
   Google Scholar
• Storms W, Kaliner MA, Javidi M, Efessiou C, Farrar J. An open-label, multicenter, single-group study to evaluate patients’ reactions to single-entity long-acting guaifenesin. Poster presented at: Annual Meeting of the Western Society of Allergy, Asthma, and Immunology (WSAAI); 1, 2008; Kailua-Kona, Hawaii, USA.
   Google Scholar
• Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. CMAJ. 2014;186(3):190–199. doi:10.1503/cmaj.12144224468694
   PubMed Web of Science ®Google Scholar
• Irwin RS. Introduction to the diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):25S–27S. doi:10.1378/chest.129.1_suppl.25S16428688
   PubMed Web of Science ®Google Scholar
• Madison JM, Irwin RS. Cough: a worldwide problem. Otolaryngol Clin North Am. 2010;43(1):1–13. doi:10.1016/j.otc.2009.11.00120172252
   PubMed Web of Science ®Google Scholar
• Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831.25420096
   PubMed Web of Science ®Google Scholar
• Dicpinigaitis PV, Allusson VR, Baldanti A, Nalamati JR. Ethnic and gender differences in cough reflex sensitivity. Respiration. 2001;68(5):480–482. doi:10.1159/00005055411694809
   PubMed Web of Science ®Google Scholar